Bridgeway Capital Management, LLC United Therapeutics Corp Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $1.38 Million - $1.61 Million	-13,600 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $31.7 Million - $44.9 Million	-295,430 Reduced 95.6%	13,600 $1.53 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $581,042 - $741,272	4,900 Added 1.61%	309,030 $45.7 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $34.9 Million - $41.6 Million	304,130	304,130 $35.6 Million

671

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.